Shift from first generation antipsychotics to olanzapine may improve health-related quality of life of stable but residually symptomatic schizophrenic outpatients: A prospective, randomized study

International Journal of Technology Assessment in Health Care

Volumn 24, Issue 4, 2008, Pages 399-402

  Joffe, Grigori ^a   Sintonen, Harri ^a   Appelberg, Björn ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

15D; Atypical antipsychotics; Conventional antipsychotics; Olanzapine; Schizophrenia

Indexed keywords

JOINT PROSTHESES;

15D; ATYPICAL ANTIPSYCHOTICS; CONVENTIONAL ANTIPSYCHOTICS; OLANZAPINE; SCHIZOPHRENIA;

SUPERCONDUCTING WIRE;

OLANZAPINE;

ARTICLE; FEMALE; HEALTH SURVEY; HUMAN; MALE; OUTPATIENT; QUALITY OF LIFE; SCHIZOPHRENIA; SCORING SYSTEM; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; MALE; QUALITY OF LIFE; SCHIZOPHRENIA;

EID: 53149130214     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462308080525     Document Type: Article

References (10)

1. Appelberg B, Tuisku K, Joffe G. Is it worth while changing clinically stable schizophrenic out-patients with mild to moderate residual symptoms and/or side effects from conventional to atypical antipsychotics? A prospective, randomized study with olanzapine. Eur Psychiatry. 2004;19:516-518.
2. Kattainen E, Meriläinen P, Sintonen H. Sense of coherence and health-related quality of life among patients undergoing coronary artery bypass grafting or angioplasty. Eur J Cardiovasc Nurs. 2006;5:21-30.
3. Revicki DA, Genduso LA, Hamilton SH, Ganoczy D, Beasley CM. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: Quality of life and clinical outcomes of a randomized clinical trial. Qual Life Res. 1999;6:417-426.
4. Räsänen P, Öhman J, Sintonen H, et al. Cost-utility analysis of routine neurosurgical spinal surgery. J Neurosurg Spine. 2006;5:204-209.
5. Räsänen P, Krootila K, Sintonen H, et al. Cost-utility of routine cataract surgery. Health Qual Life Outcomes. 2006;4:74.
6. Räsänen P, Paavolainen P, Sintonen H, et al. Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthopaed. 2007;78:108-115.
7. Sintonen H. Outcome measurement in acid-related diseases. Pharmacoeconomics. 1994;5(suppl 3):17-26.
8. Sintonen H. The 15D instrument of health-related quality of life: Properties and applications. Ann Med. 2001;33:328-336.
9. Strakowski SM, Johnson JL, Delbello MP, et al. Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. Schisophr Res. 2005;78:161-169.
10. Voruganti L, Cortese L, Oyewumi L, et al. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side effect profile and impact on quality of life. Schizophr Res. 2000;43:135-145.